Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Sep 12, 2022 10:24am
107 Views
Post# 34956416

RE:RE:RE:Pezgoof, I have never made fun of stuttering.

RE:RE:RE:Pezgoof, I have never made fun of stuttering. It is funny to see that Stockings/Stutters have no interest in the company but continue to attack for their own pleasure.  He still shows no focus on the business, no interest in the shares ... yet here he is all the same.

A little truth from him would go a long way I'm sure - then - a little more listening and a lot less talk would serve him well.  He really don't get it and would never admit to that.

I love the absolute connection he makes between public speaking and share price ... yet ... there is a more fundemental reason for the exit of retail shareholders.  There is a pattern in pharma between shareholder interest and trial schedules/progress.  There's also a direct relationship between analyst's message and retail buying behavior.

Yet - searching for a reason only goes as deep as once can see - no further.  Simply love the psychology of today's wanna-be investor, which I'm sure is passed down through the decades.

---------------

As a retail investor, the most important questions for any company ... are ... can I contact management and get a response to my questions?  Is management willing to engage?  Do they come across in an honest and caring way?

If the answer is "NO" to any one of those questions, that company has already lost me as a potential investor.  And my friends, this first hurdle of investing is failed by >99% of the companies I try to pursue.

The weeding out process gets more complex and more interesting from that point forward but one thing is for sure ... I wouldn't let any amount of stuttering get in the way of my interest in the company.  Would I let a CEO know if there was something they did that was rather annoying and they could learn from?  Already have.  And I know my comments were well received and improved on.

In this case - wrt Dan searching for appropriate words ... grow up!  I suggest you look at a few other (more important traits) to guide your understanding of a business, their IP and their go-forward strategy.  And if you're going to make fun of his legal background - I think you might want to ask how that background could help a business that's heavily indebted to IP generation.  If you're going to make fun of his military background, I think you should ask about his oath and his commitment to his team before you draw other off-the-wall conclusions.

Just saying there are different ways to look at any scenario.  Just make sure you draw the right conclusions.  Being wrong can cause you to miss opportunities.

I'm not saying I'm right - I'm just saying think about your approach.  Listen before you speak.  Speak with understanding.  Don't jump too quickly to assume you have the answers - we know you don't.






Inthepez wrote:

I guess this wouldn't be the first time someone spoke to themselves using 2 different forums. Reminds me of the dumpster messaging Czechcashings and then lying about it. deja vu LOL! 


get back on your medication stutters for brains, stockingslover or whatever you call yourself! Lol


 

StockingUp21 wrote:

 

like putting pez as a teacher in anger management classes. Or pez as a kindergarten teacher when he is a smart as a kindergarten student 

 

Stutters wrote:
I do however think that he should let someone else speak for the company as he is (in my opinion) a horrible public speaker and this in turn effects the share price and chance of any future success.

 

 





<< Previous
Bullboard Posts
Next >>